|
RNA | Avidity Biosciences, Inc. |
|
|
RNA | Avidity Biosciences, Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.42 |
| Leverage | 12.88% |
| Market Cap | $ 2.9B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -454.6m |
| Margin | -4746.82% |
Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California.